Leadership & Staff

Staff Leadership

      • David Arons

        David F. Arons, JD

        Chief Executive Officer

        David Arons is the Chief Executive Officer of National Brain Tumor Society. He previously served in leadership and external positions at the American Cancer Society in Minnesota, the Center for Lobbying in the Public Interest and at Independent Sector. As an attorney, he previously represented patients facing disabilities and serious health conditions. He is the author of several books, including Power in Policy: A Funder’s Guide to Advocacy and Civic ParticipationStrengthening Nonprofit Advocacy, and A Voice for Nonprofits. He serves on the National Cancer Institute’s Council of Research Advocates and Clinical Trials Advisory Committee. In 2016, Mr. Arons was named to the Blue Ribbon Panel of experts selected to help advise the National Cancer Moonshot, being led by Vice President Joe Biden.

      • Hall

        Lauren Hall, CFRE

        Chief Development Officer

        Lauren Hall is the Chief Development Officer at the National Brain Tumor Society. A senior development professional with nearly two decades of experience at some of the world’s leading institutions – including Dana-Farber Cancer Institute, the University of Pennsylvania, and Brigham and Women’s Hospital – Lauren has served as a frontline fundraiser for three multibillion-dollar campaigns. She has secured transformative funding from individuals, corporations, and foundations, built and managed boards and committees, and led highly successful fundraising teams. She previously served as Assistant Vice President of Development at Brigham and Women’s Hospital, where she directed fundraising for the neurosciences and played a key role in launching the Ann Romney Center for Neurologic Diseases.

      • Tanner

        Kirk Tanner, Ph.D

        Chief Scientific Officer

        Kirk Tanner is the Chief Scientific Officer at the National Brain Tumor Society. Kirk is an oncology research leader with two decades experience in discovery and development projects and programs resulting in multiple clinical candidate therapies and investigational new drugs. Formerly, he was the Research Oncology Disease Area Expert and Senior Director at Vertex Pharmaceuticals. As CSO, Kirk leads National Brain Tumor Society’s research program that aims to catalyze treatment development through philanthropic investment in medical research, engaging scientists, clinicians, patients and care partners in research programs. Kirk received his Ph.D. in chemistry from the University of California, San Diego and did post-doctoral training at Oregon Health Sciences University.

      • Gallucci

        Steve Gallucci

        Chief Financial Officer

        Steve Gallucci is the Chief Financial Officer of the National Brain Tumor Society. Steve brings to NBTS over twenty years of experience in financial leadership. He has served non-profits in human services, healthcare, and education, and for-profit organizations in biotech, professional services, and media. He has led organizations from startup to dramatic growth to acquisitions. Most recently, Steve served as a consulting CFO, providing expert council to senior leaders and Boards of Directors. Steve is a licensed CPA and received his MBA from Cornell University.

      • antonellis

        Michael Antonellis

        Chief Marketing Officer

        Michael Antonellis is Chief Marketing Officer at the National Brain Tumor Society. Mr. Antonellis is a creative leader and senior executive who develops and directs marketing strategy, vision, and all communications programs including online marketing, social engagement, and branding. He leads campaigns to drive public awareness and mindshare, build deeper engagement and loyalty from volunteers and donors, generate revenue and stewardship, and promote fundraising for research/advocacy progress. He previously served as Director of Marketing & Communications at Harte Hanks, an international marketing services company, and has held senior communications positions at VISTAGY (now Siemens), and Lois Paul & Partners, a high technology and biotechnology PR agency.

      • Nance

        Wendi Nance Huff

        Sr. Director of National Industry & Corporate Partnerships

        Wendi Nance Huff serves as the National Brain Tumor Society’s National Industry and Corporate Development Officer and oversees development strategy and execution for the organization’s health care platform and the Cure GBM and Pediatric Cancer Cure LLCs. Ms. Nance is a senior-level development professional, who most recently served as the Associate Vice President of Institutional Advancement at the Morehouse School of Medicine (MSM). She has also served as the CEO of a South Carolina chapter of the YWCA, and is an active participant on several boards and committees in South Carolina.

      • Knight

        Kristina Knight

        Director, Research and Program Partnerships

        Kristina Knight serves as the Director, Research and Program Partnerships. She oversees the vital work of our pediatric brain tumor research Initiative, supporting the LLC President. She also is part of our industry engagement team and organizes the annual NBTS Scientific Summit, among other responsibilities. Previously she worked overseeing the Marketing Communications department for seven years. Prior to working in the brain tumor community, Kris spent many years in branding and business development for small to mid-size businesses, working with non-profit, higher education, biotech, and technology clients. Kris has specialized in client services and project management, as well as working in-house to run marketing efforts.

Back to top

Board of Directors


Sarah Durham – Chair

Sarah Durham is the Chair of the National Brain Tumor Society Board of Directors. She is the Principal and Founder of Big Duck, a communications firm that works exclusively with nonprofits to help reach supporters, build awareness, and raise money. She was named a top fundraiser under 40 by Fundraising Success in 2006, and one of the most influential women in technology by Fast Company in 2010. tumor since 2000.

Thomas Roloff – Vice Chair

Thomas Roloff is the vice chairperson of the National Brain Tumor Society. He is senior vice president of Information Technology & Business Transformation at Dell Technologies Corporation. He also attended the MIT Sloan School of Management where he earned an M.B.A. Mr. Roloff was also a vice president of EMC and chief operating officer at EMC Consulting. He has also held senior management positions at Perot Systems and HomeLife Medical. He earned his undergrad degree at Lafayette University and a masters degree at Virginia Tech University.

John Frishkopf – Treasurer

John Frishkopf is the Treasurer of the National Brain Tumor Society Board of Directors and the Chair of the Programs Committee. He is a founder of NewStar Financial, Inc. from which he recently retired as Treasurer and Head of Asset Management. Mr. Frishkopf joined the board of NBTS after his husband, now deceased, was diagnosed with glioblastoma. A graduate of MIT and MIT Sloan, John Frishkopf has spoken at conferences and has published on using financial engineering techniques to speed the drug discovery process.

Robert Burger, MBA – Clerk

Robert Burger is the Clerk of the National Brain Tumor Society Board of Directors. He is also the Executive Director and Chief Operating Officer at the global intellectual property law firm of Sterne Kessler Goldstein & Fox headquartered in Washington, D.C. Rob is actively involved in other boards and earned his Bachelor of Arts from Miami University of Ohio, his Master’s degree from American University, and an MBA from Georgetown University. Rob’s aunt founded BTS, an NBTS legacy organization, after tragically losing her son Seth Harris Feldman to a Glioblastoma in December of 1988 (days before his 18th birthday).

Board Members

  • Dave Brown
  • Robert Corrao
  • David Donabedian
  • Evanthia Galanis, MD
  • Ryan Lang
  • Autumn McDonald
  • Chandri Navarro, Esq.
  • Eric Olson, PhD
  • Stephen T. Sadler, JD
  • Liz Salmi
  • Salo Zelermyer, JD

Co-Founder: G. Bonnie Feldman
The Brain Tumor Society

Co-Founder: Walter & Ellen Newman and David & Nora Plan
National Brain Tumor Foundatio

Emeritus Board Members

  • Michael Corkin
  • Richard Genderson
  • Ken Grey
  • Steve Karol
  • Sheila Killeen
  • Jeffrey Kolodin
  • Michael Nathanson, JD, LLM
  • Susan Pannullo, MD
  • Cord Schlobohm, DMD
  • Rabbi Eric B. Wisnia
  • Charles B. Wilson, MD (deceased)

Back to top

Regional Boards

Greater NY/Long Island Region

  • Kris Pollina


Mid-Atlantic Region

  • Beth Finn
  • Shari Goldstein
  • Jessica Hess
  • Mary Stein


Pac-West Region

  • Lisa O’Leary
  • Dr. Leia Nghiemphu
  • Britt Aaronson
  • Lauren Wiedmeier
  • Nancy Harris
  • Reza Sadaghiani
  • Dr. Diego Carrera
  • Terry McNiff


Southwest Region

  • J.J. Pellini

Back to top


Medical Advisory Board

  • Terri S. Armstrong, PhD, NP
    Neuro-Oncology Branch, National Cancer Institute
  • Dr. Stephen Brem, MD
    University of Pennsylvania
  • Timothy Cloughesy, MD, (Vice Chair)
    University of California, Los Angeles
  • Paul Fisher, MD
    Stanford University Medical Center
  • Sherry Fox, PhD, RN, CNRS
    Bon Secours Cancer Institute
  • Amar Gajjar, MD
    St. Jude Children’s Research Hospital
  • Mark Gilbert, MD
    Neuro-Oncology Branch, National Cancer Institute
  • Glenn Lesser, MD
    Wake Forest University Medical Center
  • Susan Pannullo, MD
    New York-Presbyterian Hospital/Weil Cornell Medical College
  • Scott Pomeroy, MD, PhD
    Boston Children’s Hospital
  • Liz Salmi
    Patient Researcher OpenNotes/Beth Israel Deaconess Medical Center
  • Jeffrey Wefel, PhD
    The University of Texas MD Anderson Cancer Center
  • Dr. Patrick Wen, MD, (Chair)
    Dana Farber Cancer Institute

Scientific Advisory Council

  • Yancey Gillespie, PhD (Chair)
    University of Alabama at Birmingham
  • Jill Barnholtz-Sloan, PhD
    Case Western Reserve University
  • Dan Cahill, MD, PhD
    Massachusetts General Hospital
  • Joseph Costello, PhD
    University of California, San Francisco
  • David Eisenstat, MD
    University of Alberta
  • Michael Lim, MD
    Johns Hopkins University
  • Duane Mitchell, MD, PhD
    University of Florida
  • Mario Suva, MD, PhD
    Massachusetts General Hospital
  • Ashley Sumrall, MD
    Levine Cancer Institute
  • Forest M. White, PhD
    Massachusetts Institute of Technology

Defeat GBM Strategic Scientific Advisory Council

  • Anna Barker, PhD
    Arizona State University
  • Mitchel S. Berger, MD, FACS, FAANS
    University of California, San Francisco
  • Lewis Cantley, PhD
    Weill Cornell Medical College
  • Webster Cavenee, PhD
    Ludwig Institute for Cancer Research, San Diego
  • William C. Hahn, MD, PhD
    Dana-Farber Cancer Institute
  • W.K. Alfred Yung, MD
    The University of Texas MD Anderson Cancer Center